Home
About
FAQ
History (12)
Long-term outcome of simultaneous kidney-pancreas transplantation: analysis of 61 patients with more than 5 years follow-up.
The use of electronic medical records for recruitment in clinical trials: findings from the Lifestyle Intervention for Treatment of Diabetes trial.
Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum Neurotoxins.
Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias.
Selecting disease-modifying medications in 5q spinal muscular atrophy.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Selecting disease-modifying medications in 5q spinal muscular atrophy.
Cartwright MS, Upadhya S. Selecting disease-modifying medications in 5q spinal muscular atrophy. Muscle Nerve. 2021 Oct; 64(4):404-412.
View in:
PubMed
subject areas
Animals
Azo Compounds
Biological Products
Humans
Muscular Atrophy, Spinal
Neuromuscular Agents
Oligonucleotides
Oligonucleotides, Antisense
Pyrimidines
Recombinant Fusion Proteins
Treatment Outcome
authors with profiles
Michael S. Cartwright MD